INTRODUCTION
Canine adenoviruses (CAVs) belonging to the family Adenoviridae are classified into CAV type 1 (CAV-1) and type 2 (CAV-2) based on the results of hemagglutination (HA), virus neutralization (VN), and molecular biological assays (1, 2) . CAVs can infect several animal species, including pet dogs, and wild animals such as wolves, coyotes, skunks, foxes, bears, and lions (3, 4) . CAV infection of unvaccinated wild raccoon dogs was confirmed by serological testing (5, 6) . CAV-1 and CAV-2 give rise to infectious canine hepatitis and infectious laryngotracheitis, respectively, due to their propensity to infect different cell types (7, 8) . CAVs are transmitted by direct contact or by exposure to infectious saliva, feces, urine, or respiratory discharges (9) .
CAV-1 can be characterized based on its cytopathic effects (CPEs) in cell culture, HA of erythrocytes, and regular icosahedral shape by electron microscopy. Diverse biological techniques, including immunofluorescence (IF) assays, are used to diagnose CAV infections in dogs (4, 10) . VN, hemagglutination inhibition (HI), and indirect IF assays also provide information on the biological features of CAVs (6, 11) .
CAV has a non-enveloped, double-stranded DNA genome of approximately 32 kb with 30 open reading frames (12, 13) . The capsid is composed of hexon, fiber, and penton base structural proteins. The fiber protein comprises tail, shaft, and knob domains and mediates CAV binding to the coxsackievirus and adenovirus receptor on host cells (14) . The fiber protein protrudes at each of the 12 vertices of the surface of the CAV capsid. An analysis of the fiber gene has enabled assessments of the HA and molecular characteristics of CAV (15) .
Although a live CAV vaccine has been manufactured for dogs in Republic of Korea since the late 1980s, its identity has not been verified by genetic characterization such as nucleotide sequencing. It is necessary for the manufacturer to improve quality control based on the biological and genetic characteristics of the vaccine strain before releasing vaccines. In this study, we investigated the biological and genetic features of the CAV-1 vaccine strain, CAV1V, which has been used to prevent CAV infection in dogs in Republic of Korea. This study will expand our understanding of CAV1V and will facilitate quality control during vaccine production.
MATERIALS AND METHODS
Virus and growth kinetics CAV1V, provided by KBNP standing for Korea Biologicals eNvironmental products Pharmaceuticals (Yesan, Korea), was propagated in Madin-Darby Canine Kidney (MDCK) cells (CCL-34; American Type Culture Collection, Manassas, VA, USA).
The MDCK cells were cultured to identify cytopathic effect (CPE) of the CAV1V strain in six-well plates at 37°C in a 5% CO 2 incubator. Confluent MDCK cells were washed twice with phosphate-buffered saline (PBS; pH 7.2), inoculated with 200 μL of 10-fold diluted CAV1V strain, and incubated for 1 h at 37°C. After adding 2 mL of Dulbecco's modified Eagle's medium (DMEM), the plate was incubated at 37°C in a humidified atmosphere containing 5% CO 2 for 2 h. Next, 5 mL of fresh DMEM containing 5% fetal bovine serum (FBS) were added and the plate was incubated at 37°C in 5% CO 2 for 7 days post-inoculation (DPI). CPEs were photographed. To assess the growth kinetics of CAV1V, MDCK cells grown in 25 cm flasks were inoculated with the virus containing 100 TCID 50 /mL and harvested daily for 7 days. After freezing and thawing three times, 10-fold serial dilutions of the virus were titrated in 96-well microplates, and CPEs were observed under a microscope at 6 DPI. The CAV1V titer was determined according to the Reed and Muench method (16) and expressed as the 50% tissue culture infectious dose (TCID 50 /mL).
Indirect immunofluorescence (IF)
MDCK cells were infected with CAV1V strain in 96-well plates and fixed in cold acetone (−20°C) for 20 min. After three successive washes with PBS (pH 7.2), the cells were reacted with a mouse monoclonal antibody against CAV-1 (VMRD, Pullman, WA, USA) for 1 h at 37°C and subsequently stained with a 100× dilution of fluorescein isothiocyanate-conjugated goat anti-mouse IgG and IgM (KPL Laboratories, Gettysburg, PA, USA). After washing with PBS, the MDCK cells were examined under a fluorescence microscope at 200× magnification (TE2000-U; Nikon Instruments Inc., Tokyo, Japan). Cells showing nuclear fluorescence were considered positive for CAV-1.
Electron microscopy
MDCK cells infected with CAV1V were harvested at 4 DPI to identify viral particles in the cells and the MDCK cells were collected from cell culture flask using a cell scraper. The infected MDCK cells were centrifuged at 1,500 × g for 5 min, and the pellet was fixed with 2.5% glutaraldehyde in PBS at 4°C for 2 h and subsequently with 1% osmium tetroxide in PBS for 2 h.
After dehydration with ethanol, the fixed cells were embedded in resin, and ultrathin sections were cut and stained with uranyl acetate and lead citrate. The stained MDCK cells were subjected to a Hitachi 7100 electron microscope (Tokyo, Japan). Copyright © 2019 Journal of Bacteriology and Virology
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CAV1V-infected MDCK cells were harvested 72 h post-inoculation to identify purified virus particles and frozen and thawed three times. After centrifugation at 4,000 × g for 30 min to remove cell debris, the supernatant was treated with saturated ammonium sulfate (MW 8,000; Sigma-Aldrich, St. Louis, MO, USA) and stirred for 2 h at room temperature. After centrifugation at 2,500 × g for 30 min, the pellet was resuspended in TE buffer (5 mM Tris-HCl and 1 mM ethylenediaminetetraacetic acid [EDTA]; pH 7.8) at 5% of the original volume. The suspension was layered on top of cesium chloride (density 1.43) and centrifuged at 100,000 × g for 90 min using a SW-41 rotor (Beckman, Danvers, MA, USA). The band on top of the cesium chloride layer was collected and, to eliminate residual cesium chloride, dialyzed against PBS overnight at 4°C. One drop of purified virus was placed on a Formvar-coated grid and negatively stained with 1% uranyl acetate. The CAV1V particles were visualized under the same electron microscope.
HA assay HA assays were performed by incubating serial two-fold dilutions of CAV1V propagated in MDCK cells in 50 L of PBS (pH 7.2) at 4°C with 50 L of 0.6% pig, guinea pig, goose, fowl, mouse, or dog erythrocytes in 0.1% bovine serum albumin (BSA) fraction V. The HA titer was expressed as the reciprocal of the highest dilution of CAV1V that showed an HA reaction.
Polymerase chain reaction (PCR)
DNA was extracted from CAV1V strain propagated in MDCK cells using a DNA Extraction Kit (Bioneer, Daejeon, Korea), according to the manufacturer's instructions. The extracted DNA was eluted in 50 μL of RNase-and DNase-free DEPC-treated water. PCR amplification of the CAV fiber gene was carried out using three primers (Table 1) . Each reaction in PCR premix (Bioneer) consisted of 10 μL of denatured DNA, 1 μL of each primer (10 pmol/L), and 38 μL of distilled water in a final volume of 50 μL. The cycling profile was denaturation at 95°C for 5 min followed by 35 cycles of denaturation at 95°C for 30 s, annealing at 55°C for 30 s, and extension at 72°C for 1 min, with a final extension at 72°C for 5 min. The products were visualized by 2.0% agarose gel electrophoresis and staining using Redsafe™ Nucleic Acid-Staining Solution (iNtRON, Seongnam, Korea). (17, 20) . PCR-based techniques can be used to diagnose CAV infections in animals (1, 21) . PCR amplification of CAV1V yielded bands at 710, 630, and 735 bp, which will facilitate its identification in actual samples. The nucleotide sequence of the fiber gene of CAV1V showed a high level of similarity to those of other CAV-1 strains, likely because of the low mutation rate of double-stranded DNA viruses (22) . A phylogenetic tree constructed based on the fiber genes of 15 CAV strains revealed CAV1V to be a CAV-1 strain and that it was most closely related to the GLAXO strain. Vaccination protects against CAV-1 and CAV-2 and should continue because CAV infections of non-immunized dogs have been reported (4) . An alignment of amino acids 200-450 of the fiber protein with those of three other CAVs showed one deletion and one insertion at positions 241 and 357, respectively. These variations in the amino acid sequence of the fiber protein of CAV-1 and CAV-2 are reportedly responsible for differences in their HA activity and tropism (15) . In addition, there is a need for further studies on the comparative analysis among vaccine strains.
In conclusion, our biological and genetic data confirm the identity of CAV1V as CAV-1. The methods and results of this study will be useful for manufacturer to carry out quality control and to prepare re-evaluation data about the CAV vaccine strain.
